Abstract:Introduction Cholestasis, as a common liver injury in clinic, increases the risk of other malignant hepatobiliary diseases such as hepatic carcinoma and cholangiocarcinoma. Estrogen‐induced cholestasis occurred in many susceptible women due to pregnancy or hormone therapy. Previous studies from our group and others suggest that AMP‐activated protein kinase (AMPK) induced phosphorylation of farnesoid X receptor (FXR), a key nuclear receptor involved in regulating bile acid homeostasis represents an important underlying mechanism of estrogen‐induced cholestasis. Most recent clinical study indicated that ursodeoxycholic acid (UDCA) monotherapy is effective in the treatment of intrahepatic cholestasis of pregnancy. However, the functional molecular/cellular mechanisms of UDCA‐mediated protective effect against estrogen‐induced cholestasis remains unclear and is the focus of this study. Methods The sandwich‐cultured rat primary hepatocytes and 17α‐ethinylestradiol (EE)‐induced rat cholestasis models were used. The protein levels were determined by Western blot analysis. The mRNA levels of targeted genes were determined by real‐time RT‐PCR. Immunofluorescent staining was used to detect canalicular structure of liver. Results EE significantly suppressed the expression of FXR and bile acid transporters via activation of AMPK signaling pathways. In rat primary hepatocytes, UDCA significantly inhibited EE‐induced AMPK activation and down‐regulation of FXR and bile acid transporters. UDCA rapidly and dose‐dependently induced phosphorylation of protein kinase A (PKA), which was correlated to its effect on inhibition of EE‐induced AMPK activation and down‐regulation of FXR expression. H89, a PKA inhibitor, blocked UDCA‐induced inhibitory effect on EE‐induced AMPK activation and downregulation of FXR and bile acid transporters. Furthermore, UDCA inhibited EE‐induced AMPK activation and downregulation of FXR and bile acids transporters in vivo rat cholestasis models. Conclusion UDCA protected hepatocytes from EE‐induced cholestatic injury via inhibiting AMPK activation. Our data also suggested that activation of PKA may also contribute to UDCA‐mediated protective effects. Support or Funding Information This poster presentation was supported by the Fundamental Research Funds for the Central Universities. And this study was supported by National Natural Science Foundation of China Grants (81320108029).

ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K

Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C

Tauroursodeoxycholate prevents estradiol 17β-d-glucuronide-induced cholestasis and endocytosis of canalicular transporters by switching off pro-cholestatic signaling pathways

Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats

NADPH oxidase-generated reactive oxygen species are involved in estradiol 17ß-d-glucuronide-induced cholestasis

Estradiol Promotes Trophoblast Viability and Invasion by Activating SGK1

Sandwich-cultured rat hepatocytes as an in vitro model to study canalicular transport alterations in cholestasis

Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats

Role of AMP-activated Protein Kinase Α1 in 17Α-Ethinylestradiol-induced Cholestasis in Rats.

The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats

Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver

Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis

UDCA Prevents 17α‐Ethinylestradiol‐induced Cholestatic Injury via Inhibiting AMP‐activated Protein Kinase Activation

UDCA and CDCA Alleviate 17Α-Ethinylestradiol-induced Cholestasis Through PKA-AMPK Pathways in Rats.

Psoralen and Isopsoralen, Two Estrogen -Like Natural Products from Psoraleae Fructus, Induced Cholestasis via Activation of ERK1/2

Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes

Ursodeoxycholic acid and 18β-glycyrrhetinic acid alleviate ethinylestradiol-induced cholestasis via downregulating RORγt and CXCR3 signaling pathway in iNKT cells

Redundant Functions of ERK1 and ERK2 Maintain Mouse Liver Homeostasis Through Down‐Regulation of Bile Acid Synthesis

Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPAR

Estradiol Represses Prolactin-Induced Expression of Na+/taurocholate Cotransporting Polypeptide in Liver Cells Through Estrogen Receptor-Alpha and Signal Transducers and Activators of Transcription 5A.